Free Trial

Traws Pharma (TRAW) SEC Filings & 10K Form

Traws Pharma logo
$4.99
-0.05 (-0.99%)
(As of 11/1/2024 ET)

Recent Traws Pharma SEC Filings

DateFilerForm TypeView
11/01/2024
4:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
4:00 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form ARS
10/11/2024
7:46 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form DEF 14A
09/27/2024
4:10 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
5:44 PM
ORBIMED ADVISORS LLC (Filed by)
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Form SC 13D
09/23/2024
3:42 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
4:06 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:11 PM
Greenwood Luba (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
4:12 PM
Greenwood Luba (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:02 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 424B3
08/28/2024
11:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form EFFECT
08/23/2024
4:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:30 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
5:03 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form NT 10-Q
08/09/2024
5:00 AM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form DEF 14A
08/07/2024
2:46 PM
Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4/A
08/07/2024
2:47 PM
Dukes Iain D. (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4/A
07/30/2024
2:14 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form PRER14A
07/19/2024
3:01 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2024
3:49 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/21/2024
4:21 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:20 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K/A
05/22/2024
4:25 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:27 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/16/2024
3:15 PM
Traws Pharma, Inc. (Filer)
Traws Pharma (Filer)
Form D
Notice of Exempt Offering of Securities 
04/12/2024
3:11 PM
ORBIMED ADVISORS LLC (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3/A
04/11/2024
4:41 PM
TPAV, LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3/A
04/08/2024
8:37 PM
Traws Pharma, Inc. (Subject)
Traws Pharma (Subject)
Viriom, Inc. (Filed by)
Form SC 13D
04/03/2024
7:01 PM
Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:03 PM
CAUTREELS WERNER (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:04 PM
Pauza Charles David (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:07 PM
Redfield Robert (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:50 PM
Savchuk Nikolay (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
6:51 PM
TPAV, LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
6:53 PM
CAUTREELS WERNER (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
6:54 PM
Pauza Charles David (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
6:55 PM
Redfield Robert (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
6:56 PM
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
6:57 PM
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Viriom, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2024
6:59 PM
Dukes Iain D. (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:47 PM
Dukes Iain D. (Reporting)
Traws Pharma, Inc. (Issuer)
Traws Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Crypto Crash Ahead? (27 Experts Weigh In) (Ad)

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.
03/15/2024
4:36 PM
Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:40 PM
Guerin Mark Patrick (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
3:48 PM
Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Subject)
Traws Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
3:49 PM
Guerin Mark Patrick (Reporting)
Onconova Therapeutics, Inc. (Subject)
Traws Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
4:36 PM
Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:38 PM
Guerin Mark Patrick (Reporting)
Onconova Therapeutics, Inc. (Issuer)
Traws Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:09 PM
Fruchtman Steven M (Reporting)
Onconova Therapeutics, Inc. (Subject)
Traws Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TRAW) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners